Transcode Therapeutics Stock

Transcode Therapeutics Acquisitions (Net)

Acquisitions (Net) of Transcode Therapeutics (RNAZ) as of Sep 15, 2026.

Acquisitions (Net)

0.00USD

Last updated:

Acquisitions (Net) of Transcode Therapeutics is 2026 0.00 USD. Acquisitions (Net) of Transcode Therapeutics was 2025 3,000.00 USD. It decreases by % lower compared to the previous year.

The Transcode Therapeutics Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2021
3,000.00 USD
Jan 1, 2022
0.00 USD
The Transcode Therapeutics Acquisitions (Net) history
YEARAcquisitions (Net)YoY
0.00USD-100.00%
3,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Transcode Therapeutics Stock analysis

What does Transcode Therapeutics do? Transcode Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transcode Therapeutics stock

On Eulerpool you can find the complete historical development of Acquisitions (Net) Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Transcode Therapeutics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Transcode Therapeutics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Transcode Therapeutics